Bivalent jab orders dependant on uptake, CECC saysBy Lee I-chia / Staff reporterAbout 450,000 doses of Moderna’s COVID-19 bivalent vaccine have been administered, and as eligibility was expanded yesterday, the Central Epidemic Command Center (CECC) said that it might order more if many people are willing to receive the jab. Moderna’s bivalent vaccine targets the original SARS-CoV-2 strain as well as the Omicron BA.1 subvariant. Photo: Tsai Shu-yuan, Taipei TimesHe said 11,163 people received Moderna’s bivalent booster on Sunday, taking the total number of doses administered to more than 449,000 doses. Eligibility for the bivalent vaccine was expanded to include people aged 18 to 49 who received their last dose of a COVID-19 vaccine at least three months (84 days) ago. Deputy Minister of Health and Welfare Victor Wang (王必勝), who heads the CECC, said there are still about 2.55 million doses of the bivalent vaccine in stock.

Source: Taipei Times October 12, 2022 00:13 UTC